loading
Schlusskurs vom Vortag:
$4.62
Offen:
$4.6
24-Stunden-Volumen:
235.94K
Relative Volume:
0.02
Marktkapitalisierung:
$6.91M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-16.88%
1M Leistung:
+179.27%
6M Leistung:
-75.64%
1J Leistung:
-76.10%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$4.25
$6.0356
52-Wochen-Spanne:
Value
$1.51
$59.70

Apimeds Pharmaceuticals US, Inc. Stock (APUS) Company Profile

Name
Firmenname
Apimeds Pharmaceuticals US, Inc.
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
7
Name
Twitter
Name
Nächster Verdiensttermin
2026-11-11
Name
Neueste SEC-Einreichungen
Name
APUS's Discussions on Twitter

Compare APUS vs TAK, TEVA, HLN, ZTS, UTHR

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
APUS icon
APUS
Apimeds Pharmaceuticals US, Inc.
4.58 6.91M 0 0 0 0.00
TAK icon
TAK
Takeda Pharmaceutical Co Adr
19.64 62.73B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
41.24 48.10B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.975 43.87B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
78.87 32.59B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
549.27 23.56B 3.17B 1.29B 1.01B 27.09

Apimeds Pharmaceuticals US, Inc. Aktie (APUS) Neueste Nachrichten

pulisher
Oct 09, 2026

MindWave Innovations Signs 3 Client Network Agreements in 10 Days, Extending MindChain into Climate Finance, Sports Media and Insurance; Apimeds Pharmaceuticals US Provides Required NYSE American Disclosure - GlobeNewswire Inc.

Oct 09, 2026
pulisher
Oct 07, 2026

$Apimeds Pharmaceuticals (APUS.US)$ - Moomoo

Oct 07, 2026
pulisher
Oct 06, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Oct 06, 2026
pulisher
Oct 06, 2026

Why Did Apimeds (NYSEAMERICAN:APUS) Skyrocket 42.5 Percent? - kalkine.ca

Oct 06, 2026
pulisher
Oct 06, 2026

$Apimeds Pharmaceuticals (APUS.US)$[Worship] - Moomoo

Oct 06, 2026
pulisher
Oct 05, 2026

Why Is Apimeds Pharmaceuticals Stock Gaining Monday? - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

APUS Stock Whipsaws After Huge Run, Drawing Day Traders - Timothy Sykes

Oct 05, 2026
pulisher
Oct 05, 2026

APUS Stock Whipsaws As Traders Zero In On Volatility And Cash Burn - StocksToTrade

Oct 05, 2026
pulisher
Oct 05, 2026

APUS Stock Whipsaws As Traders Target Extreme Volatility - Timothy Sykes

Oct 05, 2026
pulisher
Oct 05, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Oct 05, 2026
pulisher
Oct 05, 2026

MindWave Innovations Signs Agreement with US-Based - GlobeNewswire

Oct 05, 2026
pulisher
Oct 05, 2026

MindWave Innovations Signs Agreement With US-Based BlockAssure to Build and Operate AssureChain, an End-to-End Insurance and Reinsurance Network - Moomoo

Oct 05, 2026
pulisher
Oct 01, 2026

Apimeds Pharmaceuticals USErick Frim Resig - Moomoo

Oct 01, 2026
pulisher
Oct 01, 2026

Form 8K Apimeds Pharmaceuticals US For: 1 October By Investing.com - Investing.com Nigeria

Oct 01, 2026
pulisher
Oct 01, 2026

Apimeds Pharmaceuticals appoints Eric Sherb as chief financial officer - Investing.com

Oct 01, 2026
pulisher
Sep 30, 2026

APUS Stock Quote Price and Forecast - CNN

Sep 30, 2026
pulisher
Sep 29, 2026

Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com Nigeria

Sep 29, 2026
pulisher
Sep 29, 2026

Form 8K Apimeds Pharmaceuticals US For: 29 September By Investing.com - Investing.com India

Sep 29, 2026
pulisher
Sep 29, 2026

Apimeds Pharmaceuticals US inks two 12-month MindChain service deals for AQUAEChain and FlashChain - TradingView

Sep 29, 2026
pulisher
Sep 29, 2026

Environmental credits and match tickets feature in two new deals for Apimeds Pharmaceuticals (APUS). - Stock Titan

Sep 29, 2026
pulisher
Sep 29, 2026

Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Innovations Signs 12-Month Agreement to Build FlashChain - The Globe and Mail

Sep 29, 2026
pulisher
Sep 29, 2026

MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media - The Manila Times

Sep 29, 2026
pulisher
Sep 25, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Sep 25, 2026
pulisher
Sep 25, 2026

Apimeds Pharmaceuticals US (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings - theglobeandmail.com

Sep 25, 2026
pulisher
Sep 25, 2026

APUS Stock Volatility Explodes As Traders Pile Into Momentum - StocksToTrade

Sep 25, 2026
pulisher
Sep 25, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Sep 25, 2026
pulisher
Sep 25, 2026

APUS Stock Volatility Spikes As Traders Target Breakout - timothysykes.com

Sep 25, 2026
pulisher
Sep 25, 2026

APUS Stock Whipsaws As Traders Chase Parabolic Pharma Move - StocksToTrade

Sep 25, 2026
pulisher
Sep 24, 2026

Meta, Everpure, Akamai Technologies, Apimeds Pharmaceuticals and Costco: Why These 5 Stocks Are on Invest - Benzinga

Sep 24, 2026
pulisher
Sep 24, 2026

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Sep 24, 2026
pulisher
Sep 24, 2026

Trending Stocks Today | Apimeds Pharmaceuticals Surges 157.64% - moomoo.com

Sep 24, 2026
pulisher
Sep 24, 2026

APUS Interactive Stock Chart | Apimeds Pharmaceuticals US, Inc Stock - finance.yahoo.com

Sep 24, 2026
pulisher
Sep 24, 2026

Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening? - Benzinga

Sep 24, 2026
pulisher
Sep 24, 2026

Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000 - Benzinga

Sep 24, 2026
pulisher
Sep 24, 2026

APUS Stock Rockets On Heavy Volume As Traders Hunt Volatility - timothysykes.com

Sep 24, 2026
pulisher
Sep 24, 2026

APUS Stock Explodes Higher As Traders Target Volatile Breakout - StocksToTrade

Sep 24, 2026
pulisher
Sep 23, 2026

Form 8K Apimeds Pharmaceuticals US For: 23 September By Investing.com - Investing.com Nigeria

Sep 23, 2026
pulisher
Sep 18, 2026

IBN Initiates Coverage of Apimeds Pharmaceuticals US, Inc. - GlobeNewswire

Sep 18, 2026
pulisher
Sep 17, 2026

Apimeds Pharmaceuticals US (APUS) Edges Higher, Testing Key Resistance at $1.74Late Stage Breakouts - careplusvn.com

Sep 17, 2026
pulisher
Sep 11, 2026

Sungjoon Chae appointed to Apimeds Pharmaceuticals US board; serves as Co‑CEO - TradingView

Sep 11, 2026
pulisher
Sep 11, 2026

Co-CEO joins new 4-person board at Apimeds (APUS) - Stock Titan

Sep 11, 2026
pulisher
Aug 21, 2026

Apimeds Pharmaceuticals US Acquires Apitox Royalty and Market Rights From FreeT to Advance U.S. Program - TradingView

Aug 21, 2026
pulisher
Jul 13, 2026

Apimeds Pharmaceuticals US to implement 1-for-10 reverse stock split, new CUSIP 03771D201 - TradingView

Jul 13, 2026

Finanzdaten der Apimeds Pharmaceuticals US, Inc.-Aktie (APUS)

Es liegen keine Finanzdaten für Apimeds Pharmaceuticals US, Inc. (APUS) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
INM INM
$1.32
price up icon 0.76%
$1.16
price up icon 0.00%
$0.4426
price down icon 1.69%
$0.4992
price up icon 2.67%
$0.3679
price up icon 4.22%
$1.29
price down icon 3.01%
Kapitalisierung:     |  Volumen (24h):